Robaxin and Linzess drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Robaxin (methocarbamol) and Linzess (linaclotide). Common drug interactions include nasopharyngitis among females and arthritis among males.

The phase IV clinical study analyzes what interactions people have when they take Robaxin and Linzess. It is created by eHealthMe based on reports of 92 people who take the same drugs from the FDA, and is updated regularly.

What is Robaxin?

Robaxin has active ingredients of methocarbamol. It is often used in muscle spasms. eHealthMe is studying from 9,109 Robaxin users. Check the latest studies of Robaxin.

What is Linzess?

Linzess has active ingredients of linaclotide. It is often used in constipation. eHealthMe is studying from 24,086 Linzess users. Check the latest studies of Linzess.



On Jul, 14, 2026

92 people who take Robaxin and Linzess together, and have interactions are studied.

Robaxin and Linzess drug interactions.

What are the common drug interactions of Robaxin and Linzess, by gender? *:

female:

  1. Nasopharyngitis (inflammation of the nasopharynx)
  2. Nephrogenic anaemia (anaemia due to kidney disease)
  3. Oesophageal stenosis (narrowing of oesophagus)
  4. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  5. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  6. Periodic limb movement disorder
  7. Scoliosis (a medical condition in which a person's spine is curved from side to side)
  8. Fall
  9. Depression
  10. Headache (pain in head)

male:

  1. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  2. Bladder disorder
  3. Blood gases
  4. Cardiac failure congestive
  5. Fall
  6. Infection
  7. Intervertebral disc protrusion (spinal disc protrusion)
  8. Muscular weakness (muscle weakness)
  9. Opiates positive
  10. Rectal prolapse (falling of rectum from normal place)

What are the common drug interactions of Robaxin and Linzess, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Abdominal pain
  2. Costochondritis (chest wall pain)
  3. Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
  4. Nausea (feeling of having an urge to vomit)
  5. Pleurisy (inflammation of the pleurae, which causes pain when breathing)
  6. Tardive dyskinesia (a disorder that involves involuntary movements)

40-49:

  1. Alopecia (absence of hair from areas of the body)
  2. Dysphagia (a condition in which swallowing is difficult or painful)
  3. Dyspnoea (difficult or laboured respiration)
  4. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  5. Kyphosis (a condition of over-curvature of the thoracic vertebrae (upper back))
  6. Lordosis (outward curve of the back bone)
  7. Menopause (end of monthly cycles in women)
  8. Oesophageal stenosis (narrowing of oesophagus)
  9. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  10. Rash

50-59:

  1. Ill-defined disorder
  2. Intervertebral disc degeneration (spinal disc degeneration)
  3. Knee arthroplasty
  4. Migraine (headache)
  5. Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  6. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  7. Muscular weakness (muscle weakness)
  8. Neck pain
  9. Neuralgia (pain in one or more nerves)
  10. Night sweats (sweating in night)

60+:

  1. Fall
  2. Diarrhoea
  3. Fatigue (feeling of tiredness)
  4. Infection
  5. Insomnia (sleeplessness)
  6. Muscular weakness (muscle weakness)
  7. Pain
  8. Pain in extremity
  9. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  10. Staphylococcal infection (an infection with staphylococcus bacteria)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 30 people, 32.61%
  2. Pain: 14 people, 15.22%
  3. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 11 people, 11.96%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 10 people, 10.87%
  5. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 9 people, 9.78%
  6. High Blood Pressure: 7 people, 7.61%
  7. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 7 people, 7.61%
  8. Depression: 7 people, 7.61%
  9. Drowsiness: 7 people, 7.61%
  10. Stress And Anxiety: 6 people, 6.52%

* Approximation only. Some reports may have incomplete information.

Do you take Robaxin and Linzess?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Robaxin and Linzess:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Robaxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Linzess:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Robaxin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Linzess and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on methocarbamol and linaclotide (the active ingredients of Robaxin and Linzess, respectively), and Robaxin and Linzess (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: